Cargando…

The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()

BACKGROUND: Severe acute respiratory syndrome (SARS) coronavirus-like viruses continue to circulate in animal reservoirs. If new mutants of SARS coronavirus do initiate another epidemic, administration of prophylactic antibodies to risk groups may supplement the stringent isolation procedures that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogaards, Johannes Antonie, Putter, Hein, Jan Weverling, Gerrit, ter Meulen, Jan, Goudsmit, Jaap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106269/
https://www.ncbi.nlm.nih.gov/pubmed/17298911
http://dx.doi.org/10.1016/j.tmaid.2006.01.007
_version_ 1783512578656305152
author Bogaards, Johannes Antonie
Putter, Hein
Jan Weverling, Gerrit
ter Meulen, Jan
Goudsmit, Jaap
author_facet Bogaards, Johannes Antonie
Putter, Hein
Jan Weverling, Gerrit
ter Meulen, Jan
Goudsmit, Jaap
author_sort Bogaards, Johannes Antonie
collection PubMed
description BACKGROUND: Severe acute respiratory syndrome (SARS) coronavirus-like viruses continue to circulate in animal reservoirs. If new mutants of SARS coronavirus do initiate another epidemic, administration of prophylactic antibodies to risk groups may supplement the stringent isolation procedures that contained the first SARS outbreak. METHOD: We developed a mathematical model to investigate the effects of hospital admission and targeted antibody prophylaxis on the reproduction number R, defined as the number of secondary cases generated by an index case, during different SARS outbreak scenarios. RESULTS: Assuming a basic reproduction number R(0)=3, admission of patients to hospital within 4.3 days of symptom onset is necessary to achieve outbreak control without the need to further reduce community-based transmission. Control may be enhanced by providing pre-exposure prophylaxis to contacts of hospitalized patients, and through contact tracing and provision of post-exposure prophylaxis. Antibody prophylaxis may also be employed to reduce R below one and thereby restrict outbreak size and duration. CONCLUSIONS: Patient isolation alone can be sufficient to control SARS outbreaks provided that the time from onset to admission is short. Antibody prophylaxis as supplemental measure generally allows for containment of higher R(0) values and restricts both the size and duration of an outbreak.
format Online
Article
Text
id pubmed-7106269
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71062692020-03-31 The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis() Bogaards, Johannes Antonie Putter, Hein Jan Weverling, Gerrit ter Meulen, Jan Goudsmit, Jaap Travel Med Infect Dis Article BACKGROUND: Severe acute respiratory syndrome (SARS) coronavirus-like viruses continue to circulate in animal reservoirs. If new mutants of SARS coronavirus do initiate another epidemic, administration of prophylactic antibodies to risk groups may supplement the stringent isolation procedures that contained the first SARS outbreak. METHOD: We developed a mathematical model to investigate the effects of hospital admission and targeted antibody prophylaxis on the reproduction number R, defined as the number of secondary cases generated by an index case, during different SARS outbreak scenarios. RESULTS: Assuming a basic reproduction number R(0)=3, admission of patients to hospital within 4.3 days of symptom onset is necessary to achieve outbreak control without the need to further reduce community-based transmission. Control may be enhanced by providing pre-exposure prophylaxis to contacts of hospitalized patients, and through contact tracing and provision of post-exposure prophylaxis. Antibody prophylaxis may also be employed to reduce R below one and thereby restrict outbreak size and duration. CONCLUSIONS: Patient isolation alone can be sufficient to control SARS outbreaks provided that the time from onset to admission is short. Antibody prophylaxis as supplemental measure generally allows for containment of higher R(0) values and restricts both the size and duration of an outbreak. Elsevier Ltd. 2007-03 2006-05-05 /pmc/articles/PMC7106269/ /pubmed/17298911 http://dx.doi.org/10.1016/j.tmaid.2006.01.007 Text en Copyright © 2006 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bogaards, Johannes Antonie
Putter, Hein
Jan Weverling, Gerrit
ter Meulen, Jan
Goudsmit, Jaap
The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
title The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
title_full The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
title_fullStr The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
title_full_unstemmed The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
title_short The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
title_sort potential of targeted antibody prophylaxis in sars outbreak control: a mathematic analysis()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106269/
https://www.ncbi.nlm.nih.gov/pubmed/17298911
http://dx.doi.org/10.1016/j.tmaid.2006.01.007
work_keys_str_mv AT bogaardsjohannesantonie thepotentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT putterhein thepotentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT janweverlinggerrit thepotentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT termeulenjan thepotentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT goudsmitjaap thepotentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT bogaardsjohannesantonie potentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT putterhein potentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT janweverlinggerrit potentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT termeulenjan potentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis
AT goudsmitjaap potentialoftargetedantibodyprophylaxisinsarsoutbreakcontrolamathematicanalysis